{"date":"2026-08-24","count":13,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6610-2026-08-24-1857-1gezg73","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-08-24","time":"18:57:47","subject":"本公司115年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜。","clause":"第37款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-08-24 18:57，「本公司115年現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-08-24-1722-iwq3ul","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-08-24","time":"17:22:51","subject":"公告本公司資訊安全長新任案","clause":"第8款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-08-24 17:22，「公告本公司資訊安全長新任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-08-24-1713-1sxmzwj","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-08-24","time":"17:13:31","subject":"本公司受邀參加寬量國際舉辦之法說會「Healthcare Corporate Day」","clause":"第30款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-08-24 17:13，「本公司受邀參加寬量國際舉辦之法說會「Healthcare Corporate Day」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-08-24-1703-x6m5w5","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-08-24","time":"17:03:32","subject":"本公司新藥CBL-514注射劑合併tirzepatide(Eli Lilly)用於減少過重或肥胖成人腹部皮下脂肪之多中心二期臨床試驗申請，今日已取得美國FDA IND核准。","clause":"第10款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-08-24 17:03，「本公司新藥CBL-514注射劑合併tirzepatide(Eli Lilly)用於減少過重或肥胖成人腹部皮下脂肪之多中心」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2026-08-24-1702-17zhr7v","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2026-08-24","time":"17:02:31","subject":"本公司受邀參加8/25永豐金證券舉辦之線上法說會","clause":"第12款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2026-08-24 17:02，「本公司受邀參加8/25永豐金證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-08-24-1604-a8fmkv","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-24","time":"16:04:51","subject":"本公司受邀參加由寬量國際舉辦之Healthcare Corporate Day","clause":"第30款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-08-24 16:04，「本公司受邀參加由寬量國際舉辦之Healthcare Corporate Day」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-08-24-1558-1oz4dpi","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-08-24","time":"15:58:53","subject":"補充公告本公司115年度現金增資發行新股之代收及專戶存儲價款行庫","clause":"第9款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-08-24 15:58，「補充公告本公司115年度現金增資發行新股之代收及專戶存儲價款行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-24-1524-sqgrt0","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-24","time":"15:24:28","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-24 15:24，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2026-08-24-1513-1sxmzwj","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2026-08-24","time":"15:13:34","subject":"本公司受邀參加寬量國際舉辦之法說會「Healthcare Corporate Day」","clause":"第12款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2026-08-24 15:13，「本公司受邀參加寬量國際舉辦之法說會「Healthcare Corporate Day」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-08-24-1504-17fe6sq","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-08-24","time":"15:04:36","subject":"代重要子公司台灣味群工業股份有限公司公告115年第一次股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-08-24 15:04，「代重要子公司台灣味群工業股份有限公司公告115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-08-24-1503-nhzt8w","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-24","time":"15:03:59","subject":"公告本公司註銷限制員工權利新股變更登記完成","clause":"第35款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-08-24 15:03，「公告本公司註銷限制員工權利新股變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6446-2026-08-24-1439-1oxzgsl","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-08-24","time":"14:39:03","subject":"本公司代子公司PharmaEssentia Japan KK公告新藥BESREMi（Ropeginterferon alfa-2b）獲日本厚生勞動省核准使用於治療原發性血小板過多症（ET）","clause":"第10款","fact_date":"2026-08-24","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-08-24 14:39，「本公司代子公司PharmaEssentia Japan KK公告新藥BESREMi（Ropeginterferon al」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6446-2026-08-24-1437-1sxmzwj","company_id":"6446","company":"藥華藥","market":"上市","industry":"生技醫療","date":"2026-08-24","time":"14:37:53","subject":"本公司受邀參加寬量國際舉辦之法說會「Healthcare Corporate Day」","clause":"第12款","fact_date":"2026-08-25","cite_as":"公開資訊觀測站重大訊息：藥華藥（6446），2026-08-24 14:37，「本公司受邀參加寬量國際舉辦之法說會「Healthcare Corporate Day」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}